Liver dysfunction, characterized by elevated levels of liver enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), has been observed in a subset of COVID-19 patients, indicating potential hepatocellular injury [8,9]. The gene discussed is GPT; the disease is COVID-19.